Foresite Capital Management, LLC is a venture capital firm and private equity. The company specialises in growth capital, buyouts, middle market and late stage investments. Its main focus is new disruptive service companies that are involved in therapeutics, health care drugs, medical devices, healthcare services and service sector with late stage technology products. Foresite Capital Management, LLC’S targets investments in genomics, biotechnology and diagnostics and seeks to invest between $10-$50 million. The company was founded in 2011 by Dr Jim Tananbaum who is both founder and Chief Executive Officer. The company’s based in San Francisco, California and has an additional New York office.
Before founding Foresite Capital, Jim Tananbaum had already co-founded 2 healthcare investment practices as well as two key biopharmaceutical companies. He graduated with a B.S. and a B.S.E.E. from Yale, obtained an M.D. FROM Harvard Medical School, earned an M.S. from MIT and finally an MBA from Harvard Business School. As he was completing Harvard Med and Business schools, he founded GelTex Pharmaceuticals that brought two different drugs onto the market for not more than $80 million. GelTex was obtained for $1.6 billion and learn more about Jim.
This was when it’s top drug Renagel had a $200 million annual revenue run rate. Renagel (Renzela) is today estimated to produce almost $1billion annually in revenue over two decades after its launch. Jim Tananbaum was also co-founder and CEO of Theravance, Inc. that shares GSK’s franchise via Innoviva with is a joint venture, and completed Theravance Biopharma, Inc which was a spin-off. Both companies combined have a market capitalization of roughly $3.2 billion and more information click here.
About Jim Tananbaum
Jim Tananbaum was recently named one of the top 100 investors on Forbes Midas list. His investment experience includes co-founding Prospect Venture Partners II and III. Earlier in his career, he was a partner at Sierra Ventures. Jim of Twitter, It is there that he helped establish the company’s healthcare services and investment practice. He has been at the forefront of numerous investments. Some of these include Amira Pharmaceuticals, which was acquired by NYSE: BMS, Amerigroup, Jazz Pharmaceuticals and Healtheon. He founded Foresite Capital in 2010 with a vision of combining elements of aspects in his career to create an original investment platform.